(Q71732644)

English

Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver

scientific article published on 01 September 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Fixed versus titrated interferon-alpha 2B in chronic hepatitis C. A randomized controlled multicenter trial. The Swiss Association for the Study of the Liver (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

J Reichen

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

L Bianchi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H Bühler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

N Dolivo

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J J Gonvers

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

D Lavanchy

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P J Malé

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E L Renner

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Schmid

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Zimmermann

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 September 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Journal of Hepatology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

275-282

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose interferon in chronic hepatitis non-A/non-B: effects on quantitative liver function and structure in a randomized, controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic viral hepatitis B and C: an argument against the conventional classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HCV RNA in patients with chronic hepatitis C treated with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Evaluation of HCV genotypes during and after long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-A, non-B post-transfusion hepatitis. Looking back in the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980112-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(96)80112-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8895005%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71732644&oldid=1933547303"